Jazz Pharma is redefining cannabis investing with Epidiolex, a fast-growing FDA-approved epilepsy drug fueling its growth.
By Nancy Lapid (Reuters) -Autism diagnoses in the United States have increased significantly since 2000, intensifying public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback